Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06800105 · ClinicalTrials.gov registry record

Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study

A clinical trial of Ovary Cancer, sponsored by University of Tennessee Graduate School of Medicine.

Recruiting
Registry status
10
Enrollment target
1
Study location

NCT06800105 is a study of Ovary Cancer that is actively recruiting participants, run by University of Tennessee Graduate School of Medicine. The registered enrollment target is 10 participants, below the 130-participant average among 10 other Ovary Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06800105, a study of Ovary Cancer, is actively recruiting participants, sponsored by University of Tennessee Graduate School of Medicine.

RECRUITING
Registry status
10 participants
Enrollment target
1
Study location

Study Summary

Minimal information is available regarding changes in whole-body metabolism in ovarian cancer patients, and no study has assessed whole-body lipid metabolism in this patient population. In this pilot study we will assess fasting and postprandial lipid metabolism of ovarian cancer patients before, during, and after treatment via indirect calorimetry.

Conditions Studied

Interventions

  • OTHER High fat smoothie

Study Locations (1)

Tennessee

  • University of Tennessee Graduate School of Medicine - Knoxville

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2023-03-22
Est. Completion 2028-03-31

What the Registry Record Tells You About NCT06800105

The ClinicalTrials.gov registry entry for NCT06800105 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 130-participant average among 10 other Ovary Cancer trials with a reported enrollment target (92% lower). The listed sponsor is University of Tennessee Graduate School of Medicine, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ovary Cancer appearing as the primary indexed condition, and to 1 intervention - of which High fat smoothie is the first listed.

NCT06800105 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT06800105 about?

NCT06800105 is a clinical study titled "Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study". Minimal information is available regarding changes in whole-body metabolism in ovarian cancer patients, and no study has assessed whole-body lipid metabolism in this patient population. In this pilot study we will assess fasting and postprandial lipid metabolism of ovarian cancer patients before, du...

What is the current status of trial NCT06800105?

This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2023-03-22. Estimated completion is 2028-03-31.

What conditions does trial NCT06800105 study?

This clinical trial studies the following conditions: Ovary Cancer.

What interventions are being tested in trial NCT06800105?

The interventions under investigation include: High fat smoothie (OTHER).

Who is sponsoring clinical trial NCT06800105?

This trial is sponsored by University of Tennessee Graduate School of Medicine, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06800105 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ovary Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.